Does damage to hypothalamic paraventricular nucleus underlie symptoms of ultradian rhythm disorder and an increased anxiety in coronavirus disease 2019? by Rosenzweig, Ivana et al.
377
www.cmj.hr
Ivana Rosenzweig1,2, Dinko Mitrečić3, Zdravko 
Petanjek4, Bobby Duffy5, Allan H. Young6, 
Alexander D. Nesbitt1,2, Mary J. Morrell7
1Sleep and Brain Plasticity Centre, Department of Neuroimaging, 
Institute of Psychiatry, Psychology and Neuroscience (IoPPN), 
King’s College London, London, UK
2Sleep Disorders Centre, Guy’s and St Thomas’ NHS Foundation 
Trust, London, UK 
ivana.1.rosenzweig@kcl.ac.uk
3Laboratory for Stem Cells, Croatian Institute for Brain Research, 
University of Zagreb School of Medicine, Zagreb, Croatia
4Center of Excellence for Basic, Clinical and Translational 
Neuroscience and Department of Anatomy and Clinical Anatomy, 
University of Zagreb School of Medicine, Zagreb, Croatia
5The Policy Institute, King’s College London, London, UK
6Department of Psychological Medicine, Institute of Psychiatry, 
Psychology, and Neuroscience, King’s College London, London, UK
7The National Heart and Lung Institute, Imperial College London, 
London, UK
Does damage to hypothalamic 
paraventricular nucleus 
underlie symptoms of 
ultradian rhythm disorder 




Croat Med J. 2020;61:377-80 
https://doi.org/10.3325/cmj.2020.61.377
Long-term physical and psychological effects of the cor-
onavirus disease-2019 (COVID-19) are yet to be fully un-
derstood, and some of them could be due to direct cen-
tral nervous system involvement. Severe acute respiratory 
syndrome coronavirus-2 (SARS-CoV-2) may directly target 
parts of the brain, more specifically the hypothalamus and 
its paraventricular nucleus, and possibly lead to increased 
prevalence of anxiety disorders.
There is increasing recognition that the COVID-2019 may, 
in some vulnerable individuals, induce prolonged post-vi-
ral fatigue states, characterized by the aberrant daytime os-
cillation in alertness, disturbed sleep cycles, and significant 
fluctuating anxiety. We propose that the striking ultradian 
nature of these fatigue states could be due to SARS-CoV-2 
direct effect on the hypothalamic paraventricular nucleus. 
We also propose that dissemination of SARS-CoV-2 to the 
hypothalamus may occur via brain’s sub-fornical organ dur-
ing any phase of the infection, and that this direct mono-
synaptic route may lead to SARS-CoV-2’s binding to the 
angiotensin-converting-enzyme-2-receptor-tagged part of 
the paraventricular nucleus. Any ensuing localized neuro-
toxicity in the pivotal region of the paraventricular neuro-
circuitry may cause significant imbalance in its key stress, 
arousal, and metabolic outputs, with important conse-
quences to our body’s physiological responses to psycho-
logical and physical stress.
There has been increased media coverage and reports of 
significant COVID-19 post-viral fatigue, aberrant daytime 
oscillation in alertness, and (often irresistible) waves of ep-
isodic anergia (1). There are reports of subjective symp-
toms that continue for weeks, sometimes months, and 
that include episodic headaches and increased fluctuat-
ing daytime anxiety, combined with disturbed nocturnal 
sleep cycles, punctuated by discernible panic attacks (eg, 
pavor nocturnus), leading to hypersomnia, or insomnia, in 
affected patients (1-3). This clinical picture appears to per-
sist in an episodic, if milder, manner, even once the main 
symptoms of the SARS-CoV-2 infection have long subsid-
ed. Anecdotally, non-hospitalized patients with mild to 
moderate COVID-19 similarly report prominent disruption 
of the 1–2 hours ultradian basic rest-activity cycle (BRAC) 
(4). The striking ultradian nature of this clinical picture is, 
as of yet, unclear.
Ultradian rhythms have long been demonstrated in vari-
ous electroencephalographic frequencies, in the tenden-
cy to fall asleep during the day, and in autonomic indi-
ces of arousal, including respiratory and heart rates 
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(4). Moreover, mood and cognitive fluctuations in several 
major neurologic (eg, Alzheimer disease) and psychiatric 
disorders (eg, depression), cluster headaches, rapid-eye-
movement (REM)–non-REM sleep cycles, hypothalamic-pi-
tuitary-axis hormone release, nasal cycles, locomotion, and 
body temperature have all been suggested to follow ultra-
dian cycles with similar periodicities (4).
A recent study by King’s College London (KCL) has high-
lighted a significant impact of the current COVID-19 pan-
FIguRe 1. The schematic illustration of the basic neuronal organization of the paraventricular nucleus (PVN) of the hypothalamus 
depicting its purported role in a four-step model of neurocircuitry of anxiety. On the left, a four-step model by Calhoon and Tye (7) 
is shown: according to this model external events are detected, interpreted, evaluated, and responded to by succeeding levels of 
highly interconnected neural circuits (adapted with permission from 7). events are further interpreted as threatening or nonthreat-
ening depending on the balance between opposing circuits; when the balance is shifted toward projections interpreting events 
as threatening, this leads to anxiety. On the right, PVN’s neurocircuitry is depicted. Afferent inputs to the nucleus arrive from many 
important integrative centers of the medulla, pons, and hypothalamus. The subfornical organ is among major inputs with identified 
angiotensin release acting directly on magnocellular and parvocellular neurons, or indirectly via intranuclear circuitry that includes 
inhibitory gamma-aminobutyric-acid (gABA) (red) and excitatory glutamate (green) interneurons. Changes within paraventricular 
angiotensin subcircuitries are described under stress condition and are reflected on release of stress hormone and arousal. gABA 
interneurons have been shown to express angiotensin-converting-enzyme-2 (ACe2) (11), and as such might be targeted by severe-
acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2). The majority of gABA interneurons have been localized to the halo zone 
surrounding the PVN, and their role as an additional gatekeeper and integrator in controlling the excitability of PVN outputs has 
been proposed (8). Any changes in the PVN circuitries, due to their major control over most of neuro-endocrine axes and neuronal 
autonomic centers, may cause robust alteration in homeostatic regulation, and through influence on regulatory brain centers 
impact on sleep and wakefulness, increased propensity to affective disorders and anxiety, and alteration of ultradian rhythms. Ab-
breviations: ad – anterodorsal nucleus of the BNST; ACe2 – angiotensin-converting-enzyme-2; AHA – anterior hypothalamic area; 
BLA – basolateral amygdala; BNST – bed nucleus of the stria terminalis; CeA – central amygdala; CeL – lateral subdivision of the 
central amygdala; CeM – centromedial subdivision of the amygdala; DVC – dorsal vagal complex; gABA – gamma-aminobutyric-acid; 
IL – infralimbic division of the mPFC; LH – lateral hypothalamus; LS – lateral septum; mPFC – medial prefrontal cortex; NAc – nucleus 
accumbens; ov – oval nucleus of the BNST; PAg – periaqueductal gray; PB – parabrachial nucleus; PL – prelimbic division of the 
mPFC; PVH/PVN – paraventricular nucleus of the hypothalamus; SARS-CoV-2 – severe-acute-respiratory-syndrome-coronavirus-2; v – 
ventral BNST; vHPC – ventral hippocampus; vPallidum – ventral pallidum; VTA – ventral tegmental area.
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demic on the quality of sleep and anxiety levels in the 
United Kingdom (UK) (5). Substantial changes to sleep and 
anxiety patterns have been reported since the UK govern-
ment announced lockdown measures. Findings from a 
survey of 2254 UK residents, aged 16-75, suggest that six 
in ten people have suffered from disturbed, unrefreshing 
sleep, of both shorter and longer duration, with more vivid 
dreams (5). The findings of the KCL survey and patients’ re-
ports are perhaps unsurprising, given the unprecedented 
situation and enormous adjustments we are undergoing 
as a society. However, we argue that SARS-CoV-2 might 
also directly contribute to described disturbed ultradian 
patterns and increased anxiety through its binding to neu-
ronal angiotensin-converting-enzyme-2 (ACE2)-receptors. 
SARS-CoV-2 can directly decrease ACE2 activity and lead 
to cell toxicity in other tissues. This interaction is believed 
to subsequently lead to a myriad of symptoms, from in-
creased blood pressure to kidney failure (3,6). We corre-
spondingly argue a direct SARS-CoV-2 effect on the specif-
ic part of the brain’s hypothalamic paraventricular nucleus 
(PVN) circuitry (Figure 1) as a neurologic mechanism that 
may, at least in part, underlie previously reported ultradi-
an disruption, and that may lead to an increased anxiety 
symptomatology (7).
It is now widely accepted that COVID-19 pathology may 
include CNS involvement (6). Dissemination of SARS-CoV-2 
across the cribriform plate of the ethmoid bone, or via 
some other CNS route (eg, area postrema, subfornical or-
gan), may occur during any phase of the infection (2,6). 
Subsequently, cells of the nervous system, including those 
controlling BRAC-ultradian-rhythms might be damaged 
by impairment of the blood-brain-barrier, by the indirect 
damage brought by hypoxia/cerebral edema and intrac-
ranial hypertension, or indeed by direct SARS-CoV-2-neu-
rocytotoxic effects. We propose that SARS-CoV-2 may tar-
get the distinct ACE2-tagged part of the PVN-subcircuitry 
(8), via a direct monosynaptic subfornical route (Figure 1), 
leading to the pleomorphic dysautonomic ultradian pre-
sentation, which is further compounded with nocturnal 
sleep fragmentation.
The PVN is an important ultradian master oscillator that 
has been proposed to regulate BRAC and the body’s physi-
ological responses to psychological and physical stress 
by initiation of a hormone cascade that eventually alters 
physiological and metabolic states (9,10). Its role in modu-
lation and triggering of the trigeminal autonomic cepha-
lalgias by mediating the regulation of nociceptive and au-
tonomic input, has similarly been proposed. Intriguingly, 
several recent studies have suggested a more versatile role 
for PVN neurons in acute behavioral changes after stress, 
by encoding the valence of encountered stimuli (7,9). Neu-
ronal ACE2 receptors, the presumed SARS-CoV-2 target 
via monosynaptic subfornical connections, are specifically 
expressed on a distinct subpopulation of GABA-ergic-in-
terneurons within PVN’s circuitry (11). The GABA-interneu-
rons act as the supernumerary (fine-tuning) gatekeepers 
that ensure a pivotal integration of the excitability of all 
PVN’s major autonomic outputs (8). PVN’s outputs (Figure 
1) include those that control key stress, arousal, and meta-
bolic functions (7).
In conclusion, given the role of PVN as a major neurocom-
putational hub that ensures adequate signal to noise inte-
gration and timely processing of multiple physiologic sig-
nals, any SARS-CoV-2-ACE2 interaction within this circuitry 
may have significant consequence. It can significantly af-
fect short-term biological rhythms that are crucial in reg-
ulating preparedness of our physiological functions for 
external world’s unpredictability. For example, in affected 
patients this might manifest itself with increased physi-
ological and emotional fragility, dysautonomia, and more 
specifically, with an increased anxiety (7). Anxiety is an im-
portant aspect of the emotional repertoire that aids aware-
ness and enables rapid responses to possible hazards (7). 
However, when physiological changes including sweating, 
dizziness, and increases in blood pressure and heart rate (7) 
are triggered by stimuli that do not pose immediate dan-
ger, or that are internally inappropriately generated, this 
can be highly debilitating (7). Future multimodal imaging 
clinical and preclinical studies are needed to validate our 
hypothesis, to further elucidate this specific ultradian post-
viral phenotype and the idiosyncratic individual sensitivity, 
as well as to help toward the long-term rehabilitation of 
the affected patients.
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